KBS REIT III Review 2026: $2.70 a Share, No Redemptions, and $918.9M of Debt Due by December

What your shares are worth

The number on your statement is the board's estimated value per share, set once a year with an independent appraiser, Kroll. The latest is $2.70, approved December 18, 2025 and based on values at September 30, 2025. Kroll's range was $2.30 to $3.13, and the board chose the approximate midpoint.

That is 77.5% below December 2018. Two statements in the 10-K tell you how fragile the remaining $2.70 is. First: "These risks are not priced into the December 18, 2025 estimated value per share," where the risks are the going-concern and market risks described just before. Second, the sensitivity: "a 1% decrease in the appraised value of the Appraised Properties would result in a decrease of $0.11" per share. By that arithmetic a fall of roughly 25% in property values would take the estimate to zero; that extrapolation is ours, not the company's.

The value also predates 2026. Since September 30, 2025 the REIT has recorded $28.4 million of impairments in the first half of 2026 and a net loss of $51.5 million for the six months. The company expects to "update our estimated value per share no later than December 2026."

Why you cannot redeem

The 10-Q is plain about it: "We terminated our share redemption program on March 15, 2024." It then explains why nothing changes soon: "we do not expect to pay any dividends or distributions or redeem any shares of common stock until certain loans are repaid or refinanced," and "One of the loans with these restrictions has a current maturity of January 2027." That loan is the $387.7 million Amended and Restated Portfolio Loan Facility, due January 22, 2027.

In 2025: "We did not redeem or repurchase any shares of our common stock during the year ended December 31, 2025." In 2026: "We did not redeem any shares of our common stock during the six months ended June 30, 2026." And on income: "We have not declared any distributions since June 2023." The filing's summary for holders is one sentence long: "Stockholders may have to hold their shares an indefinite period of time."

The loan calendar

At June 30, 2026 the REIT owed $1,246.4 million under seven loans. As of August 13, 2026 the weighted-average remaining term was 0.3 years, and the company counted "$1.2 billion of loan maturities and required principal paydowns during the next 12 months."

Add the five loans that mature in 2026 ($821.2 million) to the paydowns the other two require by year-end ($87.7 million on the portfolio facility and $10.0 million on the credit facility) and you get the $918.9 million the 10-Q schedules for July-December 2026, 73.7% of all the debt. Interest costs are also rising on their own: swaps fixed the rate on about $0.7 billion of the variable debt at June 30, only $200 million of that was still covered by mid-August, and those swaps mature November 1. The 10-Q says: "As these swaps expire, our interest expense will increase." With the swap maturities taken into account, the 10-Q estimates that rates 100 basis points higher over the twelve months to June 2027 would add $10.6 million of interest on the variable-rate debt.

The company has managed this for more than two years. It says it has refinanced, restructured or extended $1.4 billion of maturing debt since February 2024, and its loan agreements require it to sell three properties in 2026, one of which it has sold. The risk is that each extension has been shorter and more conditional than the last. This calendar is where the next change for holders will come from, and we will update this page when an 8-K or the November 10-Q moves any of these dates.

Going concern, in the company's words

The 10-Q concludes that management's plans "do not alleviate substantial doubt about the Company's ability to continue as a going concern." It describes the outcomes it is trying to avoid without softening them: "the Company may relinquish ownership of one or more secured properties to the mortgage lender," and "We may also seek the protection of the bankruptcy court to implement a restructuring plan." On The Almaden, in San Jose: "the estimated fair value of The Almaden was less than the outstanding mortgage debt."

None of that means the REIT will fail. The company still reported compliance with its financial covenants at June 30, and it has sold assets, including Park Place Village for $100.0 million in September 2025, to meet each deadline so far. It does mean the common stock sits behind $1.25 billion of notes that have to be dealt with first, and that the lenders, not the stockholders, set the timetable.

Who is paid while holders wait

On October 1, 2026 KBS REIT III filed an 8-K saying it had renewed its advisory agreement with KBS Capital Advisors LLC through September 27, 2027 (accession 0001482430-26-000041), so the fee arrangement described below runs at least one more year.

The adviser, KBS Capital Advisors, charges an annual asset management fee on the cost of the properties. In the first half of 2026 it was $8.3 million, against MFFO of $3.2 million, the REIT's own measure of recurring cash earnings. Some of it is not paid in cash: at June 30 the REIT had accrued $20.6 million of asset management fees, including $8.5 million of deferred fees and $8.5 million deposited in December 2023 into a Bonus Retention Fund "to incentivize and retain key employees of the Advisor."

The REIT also owns 237,426,088 units of Prime US REIT, a Singapore-listed office REIT, worth $38.2 million at June 30, 2026. Proceeds from those units are pledged to the portfolio lenders.

A board no one re-elected

At the July 2025 annual meeting "none of the director nominees received affirmative votes from a majority of the shares present." Under Maryland law all five directors stay in office as hold-over directors. Broker non-votes, 56,497,443 of them, counted against the nominees. Failed annual meetings are common in this category: our 2026 quorum census found six non-traded REITs that could not even seat theirs. The charter requires the conflicts committee to consider a liquidation vote, and the latest disclosed decision is that "our conflicts committee unanimously determined to postpone approval of our liquidation." The next annual meeting is expected on December 17, 2026. The next test is set: the 2026 annual meeting is called for December 17, 2026 (DEF 14A filed September 22, 2026, accession 0001482430-26-000037; record date September 21, 148,516,246 shares entitled to vote; quorum 50% of all votes), with five directors and Ernst & Young on the ballot, Broadridge paid about $15,000 to solicit proxies, and the same going-concern warning repeated in the proxy. The Q4 2026 meeting calendar tracks it alongside eleven others.

The offers for your shares

With no redemptions and no listing, the only prices on record are mini-tender offers, small offers below 5% of the shares that do not require the full tender-offer filing. The REIT answered each one by 8-K:

Each time the board said it would "remain neutral" and made no recommendation. No response to a new offer has been filed since May 2025. A buyer at $0.80 is betting that the properties are worth more than the lenders' claims by enough to cover a long wait; a seller at $0.80 is giving that bet away. How the same kind of offer played out at another former KBS vehicle is in our Pacific Oak Strategic Opportunity REIT review.

What the filings do not say

• Which properties took the 2026 impairments, and which one is being sold to meet the September 30 credit-facility deadline.
• Occupancy by property at June 30, 2026, other than Accenture Tower (88.5%), and the names of the largest tenants.
• The covenant levels and how much room is left under them.
• Whether the lender on The Almaden has been offered the property.
• Any new conflicts-committee decision on liquidation in 2026, or any merger or sale process.

What a holder can actually do

This is analysis, not advice. With redemptions closed, the choices are narrow:

1. Hold and wait for the loans to be repaid or refinanced, which is the condition for redemptions or distributions to return. The first test is the September 30 sale; the big ones are November 2 and December 15.
2. Sell to a bidder if a new mini-tender appears, knowing the last two were at $0.80, about a fifth of the value per share at the time.
3. Vote in December. A quorum and a majority are what put a board with a mandate back in place, and the liquidation question returns every year.
4. Ask a tax professional how a position whose reported value keeps falling is treated, especially inside an IRA, where the $2.70 is the number custodians use.

If you hold a large position, or advise clients who do, the useful work is reading each 8-K and the November 10-Q against this calendar; we do that as a Forensic Filing Read, every figure tied to its note, in 72 hours.

ProsCons

FAQ

Verdict

KBS REIT III earns 1.1 out of 5. What keeps it above the floor is that it still tells holders everything, down to a loan calendar with dates and conditions. What it tells them is the problem: no redemptions, no income, a value per share that has fallen more than three-quarters and excludes the risk the company itself flags, and $918.9 million of debt to repay, refinance or hand back in the next four months. For a holder there is no action that gets money out at the $2.70 today. The dates in the table above are what will decide what the shares are worth next, and the September 30 sale is the first of them.

Sources

• KBS Real Estate Investment Trust III, EDGAR filings (CIK 1482430)
• Form 10-Q for the quarter ended June 30, 2026, accession 0001482430-26-000026 (loans, maturity schedule, going concern, redemptions, fees, MFFO, occupancy, swaps, Prime US REIT units)
• Form 10-Q for the quarter ended March 31, 2026, accession 0001482430-26-000021
• Form 10-K for 2025, accession 0001482430-26-000014 (value-per-share history and sensitivity, stockholders of record, redemptions in 2025, going-concern language)
• Form 8-K, December 2025, accession 0001482430-25-000057 ($2.70 value per share)
• Form 8-K, July 2025, accession 0001482430-25-000039 (annual meeting results)
• Form 8-K, September 2025, accession 0001482430-25-000049 (Park Place Village sale)
• Forms 8-K with the company's responses to mini-tender offers: 0001482430-24-000028, 0001482430-24-000042, 0001482430-25-000014, 0001482430-25-000031